MedSpaRadar™
Free alerts

Pennsylvania med spa & injectable regulations

What’s changing for med spas and injectors in Pennsylvania — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in Pennsylvania. MedSpaRadar monitors it all and tells you, in plain language, what changed and what to do.

Opening a med spa in Pennsylvania? Start with who may own one, the medical director rules, and who may inject in Pennsylvania →

Latest Pennsylvania changes

No new Pennsylvania changes in the last 9 months. We scan the Pennsylvania legislature daily and nothing med-spa-relevant has moved since Dec 16, 2025. The Pennsylvania legislature is in session (2025-2026 Regular Session). Bills can move at any time. A quiet state is good news — the record below still applies, and the federal changes further down apply to every Pennsylvania practice today.

Federal changes that apply in Pennsylvania

FDA and Federal Register actions are nationwide — they govern Pennsylvania practices too.

See the full regulatory feed →

What we monitor in Pennsylvania

  • Pennsylvania legislature — bills on injectables, GLP-1s & scope of practice
  • Pennsylvania Attorney General — Enforcement and consumer-protection announcements.
  • U.S. FDA — enforcement, warning letters, recalls, shortages
  • Federal Register — new rules on compounding & aesthetics

Pennsylvania med spa questions, answered from statute

The same verified record, asked the way operators actually ask it — who may own one, who may inject, what the supervising physician has to do. 22 questions have a cited Pennsylvania answer today.

Browse the 22 Pennsylvania questions →

Pennsylvania med-spa compliance rules

31 rules across 7 topics — physician delegation, the good-faith exam, ownership & corporate practice of medicine, RN/NP scope, med-spa registration, advertising, and enforcement — each linked to its primary source. Reference and monitoring, not legal advice.

Ownership & corporate practice of medicine5 cited rules

For a professional corporation formed by medical doctors, the State Board of Medicine’s test for a co-owner has two parts: the co-owner must be a health care practitioner who treats human ailments and is licensed in Pennsylvania to provide health care WITHOUT receiving a referral or supervision from another…

Physician supervision & delegation6 cited rules

On the medical side Pennsylvania delegates by TEST rather than by list: seven conditions, all of which must hold before a physician delegates a medical service to a health care practitioner or a technician — with a separate standing-protocol route for emergencies.

Good-faith examination4 cited rules

Pennsylvania approaches the pre-treatment question from the DELEGATION side: the physician has to make a patient-specific judgment before anyone else touches the patient, and some services cannot be handed over at all.

RN / NP scope for injectables3 cited rules

Pennsylvania is a collaborative-agreement state for nurse practitioners, and it is prescriptive about the paperwork: the agreement must name a substitute physician for when the collaborating one is unavailable.

Med-spa registration & licensing6 cited rules

Two duties here are easily missed, and neither is a facility license: a licensee’s fictitious practice name must not be misleading, deceptive, untrue or fraudulent, and a nurse practitioner’s collaborative agreement has to be kept current with the Board.

  • Pennsylvania adopts the federal compounding regime as its own, and keeps it current. “the compounding of sterile and nonsterile preparations shall be done in accordance with section 503a of the federal food, drug, and cosmetic act … federal regulations promulgated thereunder, and the current version of the usp chapters governing compounding.” “Current version” means the standard moves without the rule being reissued.

    49 Pa. Code § 27.601 · read at Cornell Legal Information Institute

  • ⚠️ and the prohibition is the whole glp-1 question in one clause. “Pharmacists may not compound … drugs that are essentially copies of a commercially available drug product, except as provided in section 503a(b)(1)(D) of the Federal Food, Drug, and Cosmetic Act.” Where the branded GLP-1 can be obtained, a compounded version of it is an essential copy and Pennsylvania forbids compounding it — no quantity limit or supervision arrangement cures that.

    49 Pa. Code § 27.602(2) · read at Cornell Legal Information Institute

  • The other two prohibitions bound the same rule. A pharmacist may not compound drugs “identified by the FDA as withdrawn or removed from the market because the drugs were found to be unsafe or ineffective” under 21 CFR 216.24, unless used in an IRB-approved clinical trial; nor drugs the FDA has identified in the FDCA or the Code of Federal Regulations “as products which may not be compounded”. a Pennsylvania practice’s diligence question is therefore federal: what has the FDA said about this molecule.

    49 Pa. Code § 27.602(1), (3) · read at Cornell Legal Information Institute

  • A CRNP must notify the Board in writing whenever a prescriptive authority collaborative agreement is updated or terminated, filing the change form and the amended agreement with the Board and paying the prescribed fee. An agreement that quietly lapses is a live compliance gap, not a paperwork one.

    49 Pa. Code §21.285 · read at Cornell Legal Information Institute

  • A licensee may practice under a fictitious name only where that name is not misleading, deceptive, untrue or fraudulent, and where it is not otherwise prohibited by law — which is where a trading name that implies medical services the entity cannot lawfully provide would fail.

    49 Pa. Code §25.214(c) · read at Cornell Legal Information Institute

  • 💰 Pennsylvania’s cosmetology fees are published as a two-column table — “effective november 5, 2022” and “effective july 1, 2024” — so the second figure in each row is the one now charged. On initial application the rows read “Esthetician $25 $26” and “Cosmetology salon or limited practice salon $135 $142”; on biennial renewal, “Esthetician $82 $97” and “Cosmetology salon or limited practice salon $129 $144”. Changing the salon is charged separately: “Change in cosmetology salon or limited practice salon (inspection required) $100 $105”.

    49 Pa. Code § 7.2(a), (b), (c) · read at Cornell Legal Information Institute

Advertising rules3 cited rules

Disciplinary landscape4 cited rules

  • Practicing without a license, or otherwise violating the Medical Practice Act or a Board regulation, is a misdemeanor of the third degree carrying a fine of up to $2,000 or up to six months’ imprisonment for a first offense, rising to a fine of $5,000 to $20,000 and six months to one year on a second or subsequent conviction.

    Medical Practice Act of 1985 §39(a) (63 P.S. §422.39)

  • Separately from the criminal penalty, the Board may levy a civil penalty of up to $1,000 on a licensee who violates the Act, or on any person who practices medicine without being properly licensed — after affording the accused an opportunity for a hearing.

    Medical Practice Act of 1985 §39(b) (63 P.S. §422.39)

  • The Board’s corrective actions run a graduated range: deny an application, administer a public reprimand with or without probation, revoke, suspend, limit or otherwise restrict a license, require treatment or refresher education, stay a suspension on probation, or impose a monetary penalty.

    Medical Practice Act of 1985 §42(a) (63 P.S. §422.42)

  • Unprofessional conduct in Pennsylvania expressly includes incompetent performance of medical acts, fraudulent or reckless practice, unconditionally guaranteeing a cure, billing for services not performed, and offering to treat disease by a secret method the practitioner will not disclose to the Board.

    49 Pa. Code §16.61 · read at Cornell Legal Information Institute

Current as of Aug 17, 2026. Verify against the linked primary source and consult qualified counsel before acting — rules change and turn on your specific facts.

Who may perform it in Pennsylvania?

We hold Pennsylvania’s own written limits for injectable (neuromodulator, dermal filler) — read at source and cited. Check a licence against a procedure and see the rule it rests on.

Check scope in Pennsylvania →

Pennsylvania med spa compliance — FAQ

Where do Pennsylvania med spa and injectable regulations come from?
Pennsylvania med spas and injectors are governed by a mix of state and federal authorities — the Pennsylvania legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. MedSpaRadar monitors all of them for Pennsylvania and flags what changed in plain language.
Does the FDA's GLP-1 compounding guidance apply in Pennsylvania?
Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in Pennsylvania. We track those federal changes alongside any Pennsylvania-specific rules so you see the full picture for your practice.
How do I keep up with Pennsylvania regulatory changes?
MedSpaRadar sends a free weekly Brief on what changed across Pennsylvania, the FDA, and the Federal Register. Members get the exact "what to do" for their states in one daily email. It's regulatory monitoring, not legal advice.

Get Pennsylvania changes as they publish

We scan the Pennsylvania legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.

Free · unsubscribe in one click · we never sell your address

Related

← All states · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director.